Cargando…

Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study

BACKGROUND: Large observational datasets such as Clinical Practice Research Datalink (CPRD) provide opportunities to conduct clinical studies and economic evaluations with efficient designs. OBJECTIVES: Our objectives were to report the economic evaluation methodology for a cluster randomised contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Franklin, Matthew, Davis, Sarah, Horspool, Michelle, Kua, Wei Sun, Julious, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385191/
https://www.ncbi.nlm.nih.gov/pubmed/28110382
http://dx.doi.org/10.1007/s40273-016-0484-y
_version_ 1782520556770295808
author Franklin, Matthew
Davis, Sarah
Horspool, Michelle
Kua, Wei Sun
Julious, Steven
author_facet Franklin, Matthew
Davis, Sarah
Horspool, Michelle
Kua, Wei Sun
Julious, Steven
author_sort Franklin, Matthew
collection PubMed
description BACKGROUND: Large observational datasets such as Clinical Practice Research Datalink (CPRD) provide opportunities to conduct clinical studies and economic evaluations with efficient designs. OBJECTIVES: Our objectives were to report the economic evaluation methodology for a cluster randomised controlled trial (RCT) of a UK NHS-delivered public health intervention for children with asthma that was evaluated using CPRD and describe the impact of this methodology on results. METHODS: CPRD identified eligible patients using predefined asthma diagnostic codes and captured 1-year pre- and post-intervention healthcare contacts (August 2012 to July 2014). Quality-adjusted life-years (QALYs) 4 months post-intervention were estimated by assigning utility values to exacerbation-related contacts; a systematic review identified these utility values because preference-based outcome measures were not collected. Bootstrapped costs were evaluated 12 months post-intervention, both with 1-year regression-based baseline adjustment (BA) and without BA (observed). RESULTS: Of 12,179 patients recruited, 8190 (intervention 3641; control 4549) were evaluated in the primary analysis, which included patients who received the protocol-defined intervention and for whom CPRD data were available. The intervention’s per-patient incremental QALY loss was 0.00017 (bias-corrected and accelerated 95% confidence intervals [BCa 95% CI] –0.00051 to 0.00018) and cost savings were £14.74 (observed; BCa 95% CI –75.86 to 45.19) or £36.07 (BA; BCa 95% CI –77.11 to 9.67), respectively. The probability of cost savings was much higher when accounting for BA versus observed costs due to baseline cost differences between trial arms (96.3 vs. 67.3%, respectively). CONCLUSION: Economic evaluations using data from a large observational database without any primary data collection is feasible, informative and potentially efficient. Clinical Trials Registration Number: ISRCTN03000938. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40273-016-0484-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5385191
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-53851912017-04-24 Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study Franklin, Matthew Davis, Sarah Horspool, Michelle Kua, Wei Sun Julious, Steven Pharmacoeconomics Original Research Article BACKGROUND: Large observational datasets such as Clinical Practice Research Datalink (CPRD) provide opportunities to conduct clinical studies and economic evaluations with efficient designs. OBJECTIVES: Our objectives were to report the economic evaluation methodology for a cluster randomised controlled trial (RCT) of a UK NHS-delivered public health intervention for children with asthma that was evaluated using CPRD and describe the impact of this methodology on results. METHODS: CPRD identified eligible patients using predefined asthma diagnostic codes and captured 1-year pre- and post-intervention healthcare contacts (August 2012 to July 2014). Quality-adjusted life-years (QALYs) 4 months post-intervention were estimated by assigning utility values to exacerbation-related contacts; a systematic review identified these utility values because preference-based outcome measures were not collected. Bootstrapped costs were evaluated 12 months post-intervention, both with 1-year regression-based baseline adjustment (BA) and without BA (observed). RESULTS: Of 12,179 patients recruited, 8190 (intervention 3641; control 4549) were evaluated in the primary analysis, which included patients who received the protocol-defined intervention and for whom CPRD data were available. The intervention’s per-patient incremental QALY loss was 0.00017 (bias-corrected and accelerated 95% confidence intervals [BCa 95% CI] –0.00051 to 0.00018) and cost savings were £14.74 (observed; BCa 95% CI –75.86 to 45.19) or £36.07 (BA; BCa 95% CI –77.11 to 9.67), respectively. The probability of cost savings was much higher when accounting for BA versus observed costs due to baseline cost differences between trial arms (96.3 vs. 67.3%, respectively). CONCLUSION: Economic evaluations using data from a large observational database without any primary data collection is feasible, informative and potentially efficient. Clinical Trials Registration Number: ISRCTN03000938. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40273-016-0484-y) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-01-21 2017 /pmc/articles/PMC5385191/ /pubmed/28110382 http://dx.doi.org/10.1007/s40273-016-0484-y Text en © The Author(s) 2017, corrected publication 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Franklin, Matthew
Davis, Sarah
Horspool, Michelle
Kua, Wei Sun
Julious, Steven
Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study
title Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study
title_full Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study
title_fullStr Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study
title_full_unstemmed Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study
title_short Economic Evaluations Alongside Efficient Study Designs Using Large Observational Datasets: the PLEASANT Trial Case Study
title_sort economic evaluations alongside efficient study designs using large observational datasets: the pleasant trial case study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385191/
https://www.ncbi.nlm.nih.gov/pubmed/28110382
http://dx.doi.org/10.1007/s40273-016-0484-y
work_keys_str_mv AT franklinmatthew economicevaluationsalongsideefficientstudydesignsusinglargeobservationaldatasetsthepleasanttrialcasestudy
AT davissarah economicevaluationsalongsideefficientstudydesignsusinglargeobservationaldatasetsthepleasanttrialcasestudy
AT horspoolmichelle economicevaluationsalongsideefficientstudydesignsusinglargeobservationaldatasetsthepleasanttrialcasestudy
AT kuaweisun economicevaluationsalongsideefficientstudydesignsusinglargeobservationaldatasetsthepleasanttrialcasestudy
AT julioussteven economicevaluationsalongsideefficientstudydesignsusinglargeobservationaldatasetsthepleasanttrialcasestudy